Business Context and Reporting Period
This Form 8-K is a Current Report filed by Vivos Therapeutics, Inc. on September 12, 2025. The company is incorporated in Delaware and trades on the NASDAQ under the symbol VVOS. The filing primarily addresses an update to an existing At-The-Market (ATM) equity offering program.
Key Financial Metrics
This filing does not contain standard financial performance metrics such as revenue, profit, cash flow, or debt levels. The only financial figure disclosed relates to capital raising capacity:
- ATM Offering Capacity: The company may sell up to an aggregate sales price of $5,830,572 of common stock under the updated prospectus supplement.
- Shares Sold to Date: As of the filing date, the company has not sold any shares pursuant to the ATM Sales Agreement entered into on February 14, 2025.
Material Changes
The material change reported is the filing of a new prospectus supplement (the "ATM Pro Supp") on September 12, 2025. This action allows the company to continue selling shares under its existing ATM Sales Agreement with H.C. Wainwright & Co., LLC. The underlying shelf registration statement (Form S-3, File No. 333-284834) was declared effective by the SEC on September 10, 2025.
Guidance, Outlook, and Risks
The filing contains no management guidance, financial outlook, or discussion of operational risks. It includes a standard legal disclaimer stating that the report does not constitute an offer to sell securities in any state where such an offer would be unlawful prior to registration. The company is identified as an emerging growth company.
Investor Verification Checklist
- Verify the current market price of VVOS to assess the potential dilution impact of the $5,830,572 ATM offering.
- Review the February 14, 2025 Form 8-K for the full terms of the ATM Sales Agreement with H.C. Wainwright.
- Confirm the status of the shelf registration statement (File No. 333-284834) on the SEC EDGAR database.
- Check subsequent filings to determine if and when shares are actually sold under this program.